Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Haseman

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinical Nuclear Medicine|October 1, 1983
Accumulation of a bone imaging agent in liver metastases from prostate carcinomaM K Haseman
Archives of Internal Medicine|July 1, 1984
Indium 111 WBC scan in local and systemic fungal infectionsM K Haseman, K Blake, I R McDougall
Techniques in Urology|March 29, 2001
Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancerS A Rosenthal, M K Haseman, T J Polascik
Clinical Nuclear Medicine|September 1, 1996
Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlationM K Haseman, N L Reed, S A Rosenthal
Cancer Biotherapy & Radiopharmaceuticals|May 10, 2000
Capromab Pendetide imaging of prostate cancerM K Haseman, S A Rosenthal, T J Polascik
Seminars in Urology|May 1, 1995
Monoclonal antibody imaging of recurrent and metastatic prostate cancerJ K Burgers, G H Hinkle, M K Haseman
Radiology|September 1, 1979
Single mini-catheter technique for abdominal aortography and selective injectionI F Hawkins, M K Haseman, P N Gelfand
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1992
Radioimmunodetection of occult carcinoembryonic antigen-producing cancerM K Haseman, D W Brown, C A Keeling, et al.
Nuclear Medicine and Biology|August 1, 1996
Cost-effectiveness of PET imaging in clinical oncologyP E Valk, T R Pounds, R D Tesar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomyD Kahn, R D Williams, M K Haseman, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Nuclear Medicine|October 1, 1983
Accumulation of a bone imaging agent in liver metastases from prostate carcinomaM K Haseman
Archives of Internal Medicine|July 1, 1984
Indium 111 WBC scan in local and systemic fungal infectionsM K Haseman, K Blake, I R McDougall
Techniques in Urology|March 29, 2001
Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancerS A Rosenthal, M K Haseman, T J Polascik
Clinical Nuclear Medicine|September 1, 1996
Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlationM K Haseman, N L Reed, S A Rosenthal
Cancer Biotherapy & Radiopharmaceuticals|May 10, 2000
Capromab Pendetide imaging of prostate cancerM K Haseman, S A Rosenthal, T J Polascik
Seminars in Urology|May 1, 1995
Monoclonal antibody imaging of recurrent and metastatic prostate cancerJ K Burgers, G H Hinkle, M K Haseman
Radiology|September 1, 1979
Single mini-catheter technique for abdominal aortography and selective injectionI F Hawkins, M K Haseman, P N Gelfand
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1992
Radioimmunodetection of occult carcinoembryonic antigen-producing cancerM K Haseman, D W Brown, C A Keeling, et al.
Nuclear Medicine and Biology|August 1, 1996
Cost-effectiveness of PET imaging in clinical oncologyP E Valk, T R Pounds, R D Tesar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomyD Kahn, R D Williams, M K Haseman, et al.
Pageof 2